

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 6.05220079 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.79989772 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.52865744 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.43764411 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.33185558 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.22842251 |
| 7 | * regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.22036817 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.14555186 |
| 9 | neuronal action potential propagation (GO:0019227) | 5.14261374 |
| 10 | protein localization to synapse (GO:0035418) | 5.04121195 |
| 11 | synaptic vesicle maturation (GO:0016188) | 4.97330152 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.94690494 |
| 13 | glutamate secretion (GO:0014047) | 4.80612304 |
| 14 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 4.78356928 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.74844856 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.63680093 |
| 17 | behavioral response to nicotine (GO:0035095) | 4.61320253 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.57301741 |
| 19 | exploration behavior (GO:0035640) | 4.37233501 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.36119393 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.28766473 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 4.24185092 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.21417799 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 4.15755669 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 4.14748184 |
| 26 | gamma-aminobutyric acid transport (GO:0015812) | 4.14384070 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.12996388 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.11387508 |
| 29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.09512936 |
| 30 | neuron recognition (GO:0008038) | 4.05706361 |
| 31 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.95963154 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.91972725 |
| 33 | neurotransmitter transport (GO:0006836) | 3.88481941 |
| 34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.87932689 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.86561421 |
| 36 | long-term memory (GO:0007616) | 3.83911936 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.78167152 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.76770962 |
| 39 | serotonin metabolic process (GO:0042428) | 3.76486479 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.75645425 |
| 41 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.72282254 |
| 42 | positive regulation of synapse maturation (GO:0090129) | 3.71249629 |
| 43 | postsynaptic membrane organization (GO:0001941) | 3.71084262 |
| 44 | proline transport (GO:0015824) | 3.68850834 |
| 45 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.68557330 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.65348686 |
| 47 | regulation of neurotransmitter levels (GO:0001505) | 3.60426798 |
| 48 | axonal fasciculation (GO:0007413) | 3.57804904 |
| 49 | regulation of synapse structural plasticity (GO:0051823) | 3.57070728 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.53892283 |
| 51 | positive regulation of synapse assembly (GO:0051965) | 3.51616364 |
| 52 | presynaptic membrane organization (GO:0097090) | 3.51490630 |
| 53 | mechanosensory behavior (GO:0007638) | 3.49278835 |
| 54 | cerebellar granule cell differentiation (GO:0021707) | 3.48557791 |
| 55 | cellular potassium ion homeostasis (GO:0030007) | 3.44340736 |
| 56 | central nervous system myelination (GO:0022010) | 3.43422223 |
| 57 | axon ensheathment in central nervous system (GO:0032291) | 3.43422223 |
| 58 | response to histamine (GO:0034776) | 3.43069434 |
| 59 | neuromuscular process controlling posture (GO:0050884) | 3.42986730 |
| 60 | potassium ion import (GO:0010107) | 3.42685920 |
| 61 | synaptic vesicle endocytosis (GO:0048488) | 3.42396944 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.42162906 |
| 63 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.41714528 |
| 64 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.41145150 |
| 65 | regulation of vesicle fusion (GO:0031338) | 3.39855091 |
| 66 | regulation of neurotransmitter secretion (GO:0046928) | 3.38381248 |
| 67 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.36893982 |
| 68 | cochlea development (GO:0090102) | 3.34559501 |
| 69 | negative regulation of appetite (GO:0032099) | 3.33270703 |
| 70 | negative regulation of response to food (GO:0032096) | 3.33270703 |
| 71 | long-term synaptic potentiation (GO:0060291) | 3.32931299 |
| 72 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.32711723 |
| 73 | neuromuscular synaptic transmission (GO:0007274) | 3.30136798 |
| 74 | synapse assembly (GO:0007416) | 3.29682389 |
| 75 | primary amino compound metabolic process (GO:1901160) | 3.28807401 |
| 76 | regulation of synaptic plasticity (GO:0048167) | 3.27920308 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.26971800 |
| 78 | behavioral response to cocaine (GO:0048148) | 3.26708156 |
| 79 | * transmission of nerve impulse (GO:0019226) | 3.24940509 |
| 80 | neurofilament cytoskeleton organization (GO:0060052) | 3.24742016 |
| 81 | potassium ion homeostasis (GO:0055075) | 3.23736684 |
| 82 | * membrane depolarization (GO:0051899) | 3.23364380 |
| 83 | mating behavior (GO:0007617) | 3.21431934 |
| 84 | startle response (GO:0001964) | 3.21280527 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.18640886 |
| 86 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.18397979 |
| 87 | auditory behavior (GO:0031223) | 3.17922177 |
| 88 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.16687731 |
| 89 | intraspecies interaction between organisms (GO:0051703) | 3.16148967 |
| 90 | social behavior (GO:0035176) | 3.16148967 |
| 91 | regulation of neurotransmitter transport (GO:0051588) | 3.13289117 |
| 92 | parturition (GO:0007567) | 3.11198945 |
| 93 | learning (GO:0007612) | 3.10961291 |
| 94 | membrane depolarization during action potential (GO:0086010) | 3.10508540 |
| 95 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.10306871 |
| 96 | positive regulation of dendritic spine development (GO:0060999) | 3.08105821 |
| 97 | activation of protein kinase A activity (GO:0034199) | 3.07719140 |
| 98 | regulation of synapse maturation (GO:0090128) | 3.07221758 |
| 99 | prepulse inhibition (GO:0060134) | 3.07135550 |
| 100 | dendrite morphogenesis (GO:0048813) | 3.06998768 |
| 101 | * synaptic transmission (GO:0007268) | 3.05322889 |
| 102 | negative regulation of microtubule polymerization (GO:0031115) | 3.04830179 |
| 103 | neuromuscular process controlling balance (GO:0050885) | 3.03961037 |
| 104 | regulation of dendritic spine development (GO:0060998) | 3.02495511 |
| 105 | response to auditory stimulus (GO:0010996) | 3.02480201 |
| 106 | sodium ion export (GO:0071436) | 3.01626124 |
| 107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.01369350 |
| 108 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.00148824 |
| 109 | regulation of glutamate secretion (GO:0014048) | 2.99922861 |
| 110 | adult walking behavior (GO:0007628) | 2.98655451 |
| 111 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.98431593 |
| 112 | cell migration in hindbrain (GO:0021535) | 2.98055291 |
| 113 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97612703 |
| 114 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.97569589 |
| 115 | positive regulation of neurotransmitter transport (GO:0051590) | 2.95084498 |
| 116 | * membrane hyperpolarization (GO:0060081) | 2.94989694 |
| 117 | phosphorelay signal transduction system (GO:0000160) | 2.94733938 |
| 118 | behavioral defense response (GO:0002209) | 2.94575279 |
| 119 | behavioral fear response (GO:0001662) | 2.94575279 |
| 120 | detection of light stimulus involved in visual perception (GO:0050908) | 2.94527202 |
| 121 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.94527202 |
| 122 | regulation of synaptic transmission (GO:0050804) | 2.94080395 |
| 123 | regulation of respiratory system process (GO:0044065) | 2.93578719 |
| 124 | cell differentiation in hindbrain (GO:0021533) | 2.91976775 |
| 125 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.91119467 |
| 126 | potassium ion transmembrane transport (GO:0071805) | 2.88701828 |
| 127 | cellular potassium ion transport (GO:0071804) | 2.88701828 |
| 128 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.88469412 |
| 129 | positive regulation of glomerulus development (GO:0090193) | 2.85360561 |
| 130 | neuronal action potential (GO:0019228) | 2.84810971 |
| 131 | cellular sodium ion homeostasis (GO:0006883) | 2.80586463 |
| 132 | neuronal ion channel clustering (GO:0045161) | 2.79481372 |
| 133 | * multicellular organismal signaling (GO:0035637) | 2.79311569 |
| 134 | regulation of neurotransmitter uptake (GO:0051580) | 2.76371303 |
| 135 | ATP synthesis coupled proton transport (GO:0015986) | 2.74489038 |
| 136 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.74489038 |
| 137 | sulfation (GO:0051923) | 2.74228472 |
| 138 | regulation of glomerulus development (GO:0090192) | 2.74047664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EZH2_22144423_ChIP-Seq_EOC_Human | 6.00273094 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.71647848 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.27604232 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.22372034 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.17188683 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.79818331 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.79818331 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.75315101 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74901790 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.69590982 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.68037588 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.64575542 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56525541 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52086649 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48907412 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45184125 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33799796 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.31633250 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.30969377 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.27879744 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22628568 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.20436986 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18116269 |
| 24 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16916467 |
| 25 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.16080842 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.14520956 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.07340516 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94701360 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.94659464 |
| 30 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85470739 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.82571460 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.77678866 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76951919 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.74295287 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70710303 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70651484 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.68016908 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62080880 |
| 39 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59364189 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57430102 |
| 41 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.56362951 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55616733 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53921080 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46608232 |
| 45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43784195 |
| 46 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41885176 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39581234 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39322835 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38761357 |
| 50 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35383410 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34823133 |
| 52 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32859694 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32161834 |
| 54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31736808 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31117570 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30391259 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30209166 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30113786 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29563368 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27811115 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25271681 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22753651 |
| 63 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22126764 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20413032 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20340415 |
| 66 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19345287 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19029886 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17944590 |
| 69 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15437624 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14372304 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12824522 |
| 72 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12081838 |
| 73 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09756022 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08872670 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08848766 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08823000 |
| 77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08679472 |
| 78 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07113673 |
| 79 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06966131 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06747711 |
| 81 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.04878717 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04439077 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03974265 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03974265 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02159865 |
| 86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00622313 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99491184 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99159111 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98597816 |
| 90 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97543505 |
| 91 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96608440 |
| 92 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95919013 |
| 93 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95743206 |
| 94 | JUN_21703547_ChIP-Seq_K562_Human | 0.95714347 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95575805 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95445335 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94457455 |
| 98 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94138965 |
| 99 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94138965 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92203351 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92192266 |
| 102 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.91865658 |
| 103 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91277445 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.90972551 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90720475 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89818711 |
| 107 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89187065 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89065267 |
| 109 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88861645 |
| 110 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88244454 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87007872 |
| 112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86584841 |
| 113 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85596866 |
| 114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82704102 |
| 115 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.82279744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.57416579 |
| 2 | MP0003880_abnormal_central_pattern | 5.11795984 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.08481901 |
| 4 | MP0009046_muscle_twitch | 3.62359578 |
| 5 | MP0009745_abnormal_behavioral_response | 3.49262238 |
| 6 | MP0004270_analgesia | 3.28166095 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.22531578 |
| 8 | * MP0002064_seizures | 3.20920330 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.11832524 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.02472471 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.92084503 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.72830420 |
| 13 | * MP0002272_abnormal_nervous_system | 2.71087471 |
| 14 | * MP0001486_abnormal_startle_reflex | 2.56399124 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.46979183 |
| 16 | MP0002736_abnormal_nociception_after | 2.46128031 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.45483939 |
| 18 | MP0006276_abnormal_autonomic_nervous | 2.42985904 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.41689566 |
| 20 | MP0002822_catalepsy | 2.22487936 |
| 21 | * MP0002067_abnormal_sensory_capabilities | 2.19808223 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.14814255 |
| 23 | MP0001970_abnormal_pain_threshold | 2.04348640 |
| 24 | MP0008877_abnormal_DNA_methylation | 2.02610992 |
| 25 | * MP0002184_abnormal_innervation | 2.01002537 |
| 26 | MP0008569_lethality_at_weaning | 1.93670803 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.91877062 |
| 28 | MP0000778_abnormal_nervous_system | 1.90550265 |
| 29 | MP0004924_abnormal_behavior | 1.88762497 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.88762497 |
| 31 | MP0004142_abnormal_muscle_tone | 1.78304922 |
| 32 | MP0001529_abnormal_vocalization | 1.75356982 |
| 33 | MP0003122_maternal_imprinting | 1.70383100 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.63307383 |
| 35 | MP0003329_amyloid_beta_deposits | 1.63273217 |
| 36 | MP0001984_abnormal_olfaction | 1.62968719 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.58593582 |
| 38 | MP0001905_abnormal_dopamine_level | 1.57923522 |
| 39 | MP0001188_hyperpigmentation | 1.50668506 |
| 40 | * MP0000955_abnormal_spinal_cord | 1.48223314 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.47376491 |
| 42 | MP0003879_abnormal_hair_cell | 1.45427686 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.43235171 |
| 44 | * MP0002882_abnormal_neuron_morphology | 1.42392166 |
| 45 | MP0003646_muscle_fatigue | 1.42144343 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.39636905 |
| 47 | MP0006292_abnormal_olfactory_placode | 1.39374513 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.37796482 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.34122770 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.34097292 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.28379675 |
| 52 | MP0004742_abnormal_vestibular_system | 1.27964316 |
| 53 | MP0003787_abnormal_imprinting | 1.27004755 |
| 54 | MP0003123_paternal_imprinting | 1.26628054 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.24175221 |
| 56 | MP0004858_abnormal_nervous_system | 1.22265813 |
| 57 | MP0004885_abnormal_endolymph | 1.19913902 |
| 58 | MP0004147_increased_porphyrin_level | 1.16105166 |
| 59 | MP0000751_myopathy | 1.12909979 |
| 60 | * MP0002152_abnormal_brain_morphology | 1.11811214 |
| 61 | MP0003633_abnormal_nervous_system | 1.11628301 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.05867854 |
| 63 | MP0008872_abnormal_physiological_respon | 1.04671089 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.04339210 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.03083587 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.01846350 |
| 67 | MP0003631_nervous_system_phenotype | 1.01706864 |
| 68 | MP0002229_neurodegeneration | 1.00930159 |
| 69 | MP0002638_abnormal_pupillary_reflex | 0.99514514 |
| 70 | MP0003283_abnormal_digestive_organ | 0.95468403 |
| 71 | MP0003938_abnormal_ear_development | 0.94937841 |
| 72 | MP0002069_abnormal_eating/drinking_beha | 0.93399890 |
| 73 | * MP0001963_abnormal_hearing_physiology | 0.89999849 |
| 74 | MP0004043_abnormal_pH_regulation | 0.89490232 |
| 75 | MP0003011_delayed_dark_adaptation | 0.88187847 |
| 76 | MP0005535_abnormal_body_temperature | 0.87349879 |
| 77 | * MP0002752_abnormal_somatic_nervous | 0.87289384 |
| 78 | MP0004085_abnormal_heartbeat | 0.86903228 |
| 79 | MP0005409_darkened_coat_color | 0.86739714 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 0.85925661 |
| 81 | MP0002160_abnormal_reproductive_system | 0.82918034 |
| 82 | MP0003632_abnormal_nervous_system | 0.82566664 |
| 83 | MP0005394_taste/olfaction_phenotype | 0.82371324 |
| 84 | MP0005499_abnormal_olfactory_system | 0.82371324 |
| 85 | MP0008874_decreased_physiological_sensi | 0.81736907 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.81494645 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.76380059 |
| 88 | MP0003878_abnormal_ear_physiology | 0.76380059 |
| 89 | MP0003634_abnormal_glial_cell | 0.75259488 |
| 90 | MP0004130_abnormal_muscle_cell | 0.75235381 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.74502859 |
| 92 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74049456 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.73865682 |
| 94 | MP0001177_atelectasis | 0.72431198 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.72109439 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.71931145 |
| 97 | MP0000920_abnormal_myelination | 0.71635286 |
| 98 | MP0002234_abnormal_pharynx_morphology | 0.69427357 |
| 99 | MP0005253_abnormal_eye_physiology | 0.68553194 |
| 100 | MP0004484_altered_response_of | 0.67662863 |
| 101 | MP0001485_abnormal_pinna_reflex | 0.67095692 |
| 102 | MP0005389_reproductive_system_phenotype | 0.66962930 |
| 103 | MP0000604_amyloidosis | 0.66186838 |
| 104 | MP0005195_abnormal_posterior_eye | 0.65577690 |
| 105 | MP0004134_abnormal_chest_morphology | 0.64475571 |
| 106 | MP0006072_abnormal_retinal_apoptosis | 0.64409858 |
| 107 | MP0002090_abnormal_vision | 0.64096629 |
| 108 | MP0003690_abnormal_glial_cell | 0.63186619 |
| 109 | MP0001664_abnormal_digestion | 0.62807648 |
| 110 | MP0003121_genomic_imprinting | 0.61901753 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.61532716 |
| 112 | MP0001943_abnormal_respiration | 0.61107872 |
| 113 | MP0004133_heterotaxia | 0.60921023 |
| 114 | * MP0000026_abnormal_inner_ear | 0.60355590 |
| 115 | MP0002102_abnormal_ear_morphology | 0.59669356 |
| 116 | * MP0003861_abnormal_nervous_system | 0.57003787 |
| 117 | MP0001919_abnormal_reproductive_system | 0.56447922 |
| 118 | MP0005187_abnormal_penis_morphology | 0.55892970 |
| 119 | MP0009379_abnormal_foot_pigmentation | 0.54898290 |
| 120 | * MP0010769_abnormal_survival | 0.54429911 |
| 121 | * MP0002082_postnatal_lethality | 0.54213222 |
| 122 | * MP0010770_preweaning_lethality | 0.54213222 |
| 123 | * MP0010768_mortality/aging | 0.51668784 |
| 124 | * MP0003956_abnormal_body_size | 0.49543487 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.46703447 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.46392359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.09383511 |
| 2 | Myokymia (HP:0002411) | 6.18857216 |
| 3 | Focal seizures (HP:0007359) | 6.02791586 |
| 4 | Atonic seizures (HP:0010819) | 5.58546724 |
| 5 | Visual hallucinations (HP:0002367) | 5.51337923 |
| 6 | Febrile seizures (HP:0002373) | 5.07425391 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.97853178 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.92127680 |
| 9 | Absence seizures (HP:0002121) | 4.75156710 |
| 10 | Dialeptic seizures (HP:0011146) | 4.29576916 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.10210650 |
| 12 | Broad-based gait (HP:0002136) | 3.96960557 |
| 13 | Action tremor (HP:0002345) | 3.67931339 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.63203002 |
| 15 | Hyperventilation (HP:0002883) | 3.56123614 |
| 16 | Dysdiadochokinesis (HP:0002075) | 3.23789247 |
| 17 | Truncal ataxia (HP:0002078) | 3.15931307 |
| 18 | Progressive inability to walk (HP:0002505) | 3.14500114 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.12913886 |
| 20 | Amblyopia (HP:0000646) | 3.12372736 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.12368782 |
| 22 | Poor eye contact (HP:0000817) | 3.11424481 |
| 23 | Limb dystonia (HP:0002451) | 3.02566432 |
| 24 | Dysmetria (HP:0001310) | 3.00753866 |
| 25 | Anxiety (HP:0000739) | 3.00389715 |
| 26 | Mutism (HP:0002300) | 2.97772017 |
| 27 | Congenital stationary night blindness (HP:0007642) | 2.93188096 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.87053689 |
| 29 | Impaired social interactions (HP:0000735) | 2.86116078 |
| 30 | Abnormal social behavior (HP:0012433) | 2.86116078 |
| 31 | Polyphagia (HP:0002591) | 2.83651017 |
| 32 | Ankle clonus (HP:0011448) | 2.81297889 |
| 33 | Depression (HP:0000716) | 2.80975978 |
| 34 | Hemiparesis (HP:0001269) | 2.77673653 |
| 35 | Drooling (HP:0002307) | 2.74884077 |
| 36 | Excessive salivation (HP:0003781) | 2.74884077 |
| 37 | Scanning speech (HP:0002168) | 2.70360967 |
| 38 | Pancreatic cysts (HP:0001737) | 2.68876949 |
| 39 | Diplopia (HP:0000651) | 2.63631655 |
| 40 | Abnormality of binocular vision (HP:0011514) | 2.63631655 |
| 41 | Impaired smooth pursuit (HP:0007772) | 2.60395086 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.59435223 |
| 43 | Genetic anticipation (HP:0003743) | 2.57956239 |
| 44 | Vaginal atresia (HP:0000148) | 2.57616195 |
| 45 | Chorioretinal atrophy (HP:0000533) | 2.57255314 |
| 46 | Optic nerve hypoplasia (HP:0000609) | 2.57006056 |
| 47 | Abnormality of macular pigmentation (HP:0008002) | 2.56520867 |
| 48 | Septo-optic dysplasia (HP:0100842) | 2.55238840 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.53545550 |
| 50 | Genital tract atresia (HP:0001827) | 2.53354372 |
| 51 | Abolished electroretinogram (ERG) (HP:0000550) | 2.47982416 |
| 52 | Epileptiform EEG discharges (HP:0011182) | 2.47882836 |
| 53 | Abnormality of the labia minora (HP:0012880) | 2.47626124 |
| 54 | Status epilepticus (HP:0002133) | 2.45087027 |
| 55 | Facial shape deformation (HP:0011334) | 2.44679183 |
| 56 | Potter facies (HP:0002009) | 2.44679183 |
| 57 | Fetal akinesia sequence (HP:0001989) | 2.42807182 |
| 58 | Medial flaring of the eyebrow (HP:0010747) | 2.42738454 |
| 59 | Inability to walk (HP:0002540) | 2.41564833 |
| 60 | Absent speech (HP:0001344) | 2.40678679 |
| 61 | EEG with generalized epileptiform discharges (HP:0011198) | 2.38620486 |
| 62 | Spastic gait (HP:0002064) | 2.38590548 |
| 63 | Mitochondrial inheritance (HP:0001427) | 2.38044093 |
| 64 | Pendular nystagmus (HP:0012043) | 2.37283130 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 2.36572889 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 2.36572889 |
| 67 | Agitation (HP:0000713) | 2.35419181 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.35279636 |
| 69 | Abnormality of the corticospinal tract (HP:0002492) | 2.33624166 |
| 70 | Pheochromocytoma (HP:0002666) | 2.33607778 |
| 71 | Hemiplegia (HP:0002301) | 2.32574831 |
| 72 | True hermaphroditism (HP:0010459) | 2.32432278 |
| 73 | Type II lissencephaly (HP:0007260) | 2.30594139 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.29795202 |
| 75 | Failure to thrive in infancy (HP:0001531) | 2.29564648 |
| 76 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28877875 |
| 77 | Postural instability (HP:0002172) | 2.28441549 |
| 78 | Nephronophthisis (HP:0000090) | 2.27837469 |
| 79 | Intention tremor (HP:0002080) | 2.26463572 |
| 80 | Urinary urgency (HP:0000012) | 2.26244390 |
| 81 | Generalized myoclonic seizures (HP:0002123) | 2.26221341 |
| 82 | Gait imbalance (HP:0002141) | 2.25845743 |
| 83 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.23547521 |
| 84 | Sleep apnea (HP:0010535) | 2.23282536 |
| 85 | Hypsarrhythmia (HP:0002521) | 2.22655499 |
| 86 | Stereotypic behavior (HP:0000733) | 2.18832175 |
| 87 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.18268259 |
| 88 | Termporal pattern (HP:0011008) | 2.18132879 |
| 89 | Insidious onset (HP:0003587) | 2.18132879 |
| 90 | Torticollis (HP:0000473) | 2.16770824 |
| 91 | Dysmetric saccades (HP:0000641) | 2.16096794 |
| 92 | Decreased central vision (HP:0007663) | 2.15832743 |
| 93 | Bradykinesia (HP:0002067) | 2.13825673 |
| 94 | Psychosis (HP:0000709) | 2.12466406 |
| 95 | Acute encephalopathy (HP:0006846) | 2.11061826 |
| 96 | Focal dystonia (HP:0004373) | 2.08150562 |
| 97 | Esotropia (HP:0000565) | 2.07550383 |
| 98 | Amyotrophic lateral sclerosis (HP:0007354) | 2.06877246 |
| 99 | Protruding tongue (HP:0010808) | 2.05926928 |
| 100 | Papilledema (HP:0001085) | 2.05116166 |
| 101 | Neuroendocrine neoplasm (HP:0100634) | 2.05049494 |
| 102 | Confusion (HP:0001289) | 2.04123651 |
| 103 | Specific learning disability (HP:0001328) | 2.03368292 |
| 104 | Abnormal drinking behavior (HP:0030082) | 2.02303231 |
| 105 | Polydipsia (HP:0001959) | 2.02303231 |
| 106 | Abnormal hair whorl (HP:0010721) | 2.00917912 |
| 107 | Acute necrotizing encephalopathy (HP:0006965) | 2.00350557 |
| 108 | Gait ataxia (HP:0002066) | 1.95514521 |
| 109 | Progressive macrocephaly (HP:0004481) | 1.94700232 |
| 110 | Hypoventilation (HP:0002791) | 1.94356293 |
| 111 | Abnormality of the lower motor neuron (HP:0002366) | 1.93022355 |
| 112 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91272287 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.90481916 |
| 114 | Blue irides (HP:0000635) | 1.89850802 |
| 115 | Hyperthyroidism (HP:0000836) | 1.89134841 |
| 116 | Absent/shortened dynein arms (HP:0200106) | 1.88332738 |
| 117 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.88332738 |
| 118 | Abnormality of salivation (HP:0100755) | 1.87877211 |
| 119 | Neuronal loss in central nervous system (HP:0002529) | 1.87520113 |
| 120 | Incomplete penetrance (HP:0003829) | 1.86812650 |
| 121 | Keratoconus (HP:0000563) | 1.85268328 |
| 122 | Increased corneal curvature (HP:0100692) | 1.85268328 |
| 123 | Delusions (HP:0000746) | 1.84041187 |
| 124 | Craniofacial dystonia (HP:0012179) | 1.83959023 |
| 125 | Poor suck (HP:0002033) | 1.83318720 |
| 126 | Growth hormone deficiency (HP:0000824) | 1.83015835 |
| 127 | Postural tremor (HP:0002174) | 1.82865021 |
| 128 | Increased CSF lactate (HP:0002490) | 1.82779867 |
| 129 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81491862 |
| 130 | Lower limb muscle weakness (HP:0007340) | 1.81489570 |
| 131 | Abnormality of saccadic eye movements (HP:0000570) | 1.81129388 |
| 132 | Congenital primary aphakia (HP:0007707) | 1.80728801 |
| 133 | Narrow nasal bridge (HP:0000446) | 1.79767401 |
| 134 | Ventricular fibrillation (HP:0001663) | 1.79115054 |
| 135 | Abnormality of the renal medulla (HP:0100957) | 1.78427738 |
| 136 | Retinal dysplasia (HP:0007973) | 1.78407447 |
| 137 | Asplenia (HP:0001746) | 1.76291273 |
| 138 | Absent septum pellucidum (HP:0001331) | 1.74575520 |
| 139 | Increased hepatocellular lipid droplets (HP:0006565) | 1.70674342 |
| 140 | Severe visual impairment (HP:0001141) | 1.69063478 |
| 141 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.68935547 |
| 142 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.68935547 |
| 143 | Sclerocornea (HP:0000647) | 1.67011591 |
| 144 | Hepatocellular necrosis (HP:0001404) | 1.66593994 |
| 145 | Akinesia (HP:0002304) | 1.64359491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.23530693 |
| 2 | EPHA4 | 3.52698628 |
| 3 | MAP3K4 | 3.50737202 |
| 4 | MARK1 | 3.36144120 |
| 5 | MAP3K9 | 3.35966153 |
| 6 | MAP2K7 | 3.17898825 |
| 7 | CASK | 2.85787283 |
| 8 | MAP3K12 | 2.75013327 |
| 9 | MINK1 | 2.72495950 |
| 10 | NTRK2 | 2.42161293 |
| 11 | PNCK | 2.31896771 |
| 12 | MAP2K4 | 2.25494405 |
| 13 | FRK | 2.24972582 |
| 14 | DAPK2 | 2.13626471 |
| 15 | PAK6 | 2.04845938 |
| 16 | GRK1 | 1.92445052 |
| 17 | RIPK4 | 1.78297528 |
| 18 | SIK2 | 1.75952898 |
| 19 | TNIK | 1.75204130 |
| 20 | MAPK13 | 1.73841742 |
| 21 | WNK4 | 1.66360792 |
| 22 | CDK19 | 1.63646956 |
| 23 | GRK5 | 1.62491745 |
| 24 | PLK2 | 1.59006673 |
| 25 | ZAK | 1.57617871 |
| 26 | CDK5 | 1.49748105 |
| 27 | NTRK1 | 1.43366455 |
| 28 | UHMK1 | 1.41323518 |
| 29 | DAPK1 | 1.37541596 |
| 30 | CAMKK1 | 1.36191404 |
| 31 | STK16 | 1.35552714 |
| 32 | KSR1 | 1.33625201 |
| 33 | DYRK2 | 1.33159308 |
| 34 | PRPF4B | 1.32341252 |
| 35 | KSR2 | 1.31325911 |
| 36 | PRKCG | 1.29014547 |
| 37 | CAMKK2 | 1.26187531 |
| 38 | FES | 1.25898576 |
| 39 | ARAF | 1.15325881 |
| 40 | CAMK2A | 1.15140257 |
| 41 | OXSR1 | 1.10340513 |
| 42 | STK38 | 1.10191015 |
| 43 | MAP4K2 | 1.09054850 |
| 44 | PHKG2 | 0.99361579 |
| 45 | PHKG1 | 0.99361579 |
| 46 | CAMK2B | 0.98737160 |
| 47 | TLK1 | 0.97279727 |
| 48 | TAOK3 | 0.96432426 |
| 49 | PRKD3 | 0.96378487 |
| 50 | NME1 | 0.95278069 |
| 51 | CDK18 | 0.94596783 |
| 52 | CDK15 | 0.92011916 |
| 53 | MAPK15 | 0.89516467 |
| 54 | CDK14 | 0.89128577 |
| 55 | MAP3K11 | 0.86242065 |
| 56 | SGK223 | 0.85365427 |
| 57 | SGK494 | 0.85365427 |
| 58 | STK11 | 0.84577040 |
| 59 | TYRO3 | 0.84469265 |
| 60 | DYRK1A | 0.84311098 |
| 61 | LATS2 | 0.81579439 |
| 62 | CAMK1 | 0.80542703 |
| 63 | CDK11A | 0.80473345 |
| 64 | CSNK1G2 | 0.78071229 |
| 65 | BMPR2 | 0.77329445 |
| 66 | PAK3 | 0.76359406 |
| 67 | BMPR1B | 0.74349286 |
| 68 | WNK1 | 0.74136861 |
| 69 | MAPKAPK3 | 0.73297167 |
| 70 | GRK7 | 0.72151363 |
| 71 | SGK2 | 0.71262024 |
| 72 | INSRR | 0.69257431 |
| 73 | FGR | 0.67042300 |
| 74 | MAP3K13 | 0.64755570 |
| 75 | PTK2B | 0.64163205 |
| 76 | ACVR1B | 0.63595284 |
| 77 | PRKCE | 0.62811733 |
| 78 | PRKCA | 0.62738849 |
| 79 | PRKCQ | 0.62714844 |
| 80 | SGK1 | 0.61898630 |
| 81 | CDC7 | 0.61067824 |
| 82 | CAMK2G | 0.60907291 |
| 83 | CAMK2D | 0.59864976 |
| 84 | WNK3 | 0.59536114 |
| 85 | PRKCH | 0.58792752 |
| 86 | TNK2 | 0.58780314 |
| 87 | PRKG1 | 0.58287716 |
| 88 | VRK1 | 0.58065536 |
| 89 | MARK2 | 0.57013755 |
| 90 | CSNK1G1 | 0.56326912 |
| 91 | RET | 0.56210197 |
| 92 | MUSK | 0.54459653 |
| 93 | NUAK1 | 0.52854533 |
| 94 | BCR | 0.52410850 |
| 95 | CAMK1G | 0.51343560 |
| 96 | AKT3 | 0.51227389 |
| 97 | PINK1 | 0.50719831 |
| 98 | ROCK2 | 0.50562064 |
| 99 | MAP3K6 | 0.50414005 |
| 100 | STK39 | 0.49978238 |
| 101 | CSNK1A1L | 0.49868642 |
| 102 | PRKCZ | 0.49212141 |
| 103 | TXK | 0.49118327 |
| 104 | RAF1 | 0.48724301 |
| 105 | ADRBK1 | 0.48205372 |
| 106 | MAP3K2 | 0.47744305 |
| 107 | SIK3 | 0.47530413 |
| 108 | CCNB1 | 0.47112022 |
| 109 | CSNK1A1 | 0.46407612 |
| 110 | ERBB2 | 0.45982934 |
| 111 | PKN1 | 0.45723965 |
| 112 | LIMK1 | 0.44590937 |
| 113 | RPS6KA3 | 0.43999682 |
| 114 | SGK3 | 0.42515423 |
| 115 | FER | 0.41453552 |
| 116 | MAPK12 | 0.41314530 |
| 117 | ALK | 0.41298797 |
| 118 | FYN | 0.40672955 |
| 119 | CSNK1G3 | 0.40598137 |
| 120 | PRKCB | 0.40160663 |
| 121 | MAPKAPK5 | 0.40090623 |
| 122 | GRK6 | 0.40007040 |
| 123 | CAMK4 | 0.39405652 |
| 124 | ADRBK2 | 0.38785462 |
| 125 | MAPK10 | 0.38214365 |
| 126 | CDC42BPA | 0.37416701 |
| 127 | * PRKACA | 0.37208268 |
| 128 | LMTK2 | 0.36024210 |
| 129 | PDPK1 | 0.35992580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.43300324 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.50814910 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.95139612 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.85310424 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.66742008 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.59785814 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.59120261 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58496850 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.50609851 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.41206952 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 2.19376331 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19363117 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.13015728 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03278140 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.96207242 |
| 16 | Long-term depression_Homo sapiens_hsa04730 | 1.95473673 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.92976232 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.87056791 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82759960 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78495251 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.71891720 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68326077 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.66486216 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.65585255 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61381659 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60275082 |
| 27 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51425439 |
| 28 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50611282 |
| 29 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.45986622 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41508889 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37291268 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.36616325 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35823256 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.31806048 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30832437 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29990634 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17977177 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.17679916 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12616673 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10844346 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07841003 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.07044687 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05438068 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01769669 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01441162 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00686104 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99000343 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97354041 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.95224829 |
| 50 | Protein export_Homo sapiens_hsa03060 | 0.93462226 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92758538 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92426169 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90809042 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90204188 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83592642 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82555181 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.81578477 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80598826 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76400652 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74384132 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71621639 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70823778 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70305318 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68771236 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67349037 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64454032 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63370036 |
| 68 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63109827 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62440939 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61484656 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61371685 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61221376 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60551342 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60339244 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59626606 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58885165 |
| 77 | RNA polymerase_Homo sapiens_hsa03020 | 0.58363152 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56092971 |
| 79 | Ribosome_Homo sapiens_hsa03010 | 0.55210345 |
| 80 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54762238 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.54041418 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53997729 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53581660 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53318104 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52592608 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.51389768 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49419226 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45188474 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45059743 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44376842 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44267968 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43956682 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43309617 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42983167 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42853695 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42829342 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42117193 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41524611 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41499521 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41219929 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40715359 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40618253 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38291579 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37275419 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37231734 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36994407 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36312964 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34317827 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34065058 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33331080 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33122530 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32657743 |
| 113 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.32615585 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.29904160 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.29533220 |
| 116 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28338834 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27933549 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.27175370 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.25117018 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24745348 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24658714 |
| 122 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24292137 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23472771 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22458148 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.22349732 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.21458084 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.20659772 |

